Raymond James & Associates Opko Health, Inc. Transaction History
Raymond James & Associates
- $146 Billion
- Q1 2024
A detailed history of Raymond James & Associates transactions in Opko Health, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 38,265 shares of OPK stock, worth $46,683. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,265
Previous 38,965
1.8%
Holding current value
$46,683
Previous $58,000
22.41%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding OPK
# of Institutions
234Shares Held
155MCall Options Held
3.02MPut Options Held
888K-
Black Rock Inc. New York, NY33.2MShares$40.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.5MShares$36 Million0.0% of portfolio
-
State Street Corp Boston, MA10.2MShares$12.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.97MShares$12.2 Million0.0% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA5.81MShares$7.09 Million0.0% of portfolio
About OPKO HEALTH, INC.
- Ticker OPK
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 771,960,000
- Market Cap $942M
- Description
- OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...